[ad_1]
Digital gastrointestinal well being firm Vivante Well being introduced it closed a $31 million Sequence B funding spherical led by new investor Mercato Companions, bringing its complete elevate to $47 million.
Well being Catalyst, Intermountain Ventures, SemperVirens, 7wireVentures, Human Capital and Distributed Ventures participated within the spherical.
WHAT IT DOES
Vivante gives a platform dubbed GIThrive that gives personalised care plans. Sufferers can observe their signs and entry academic content material and self-guided behavioral well being modules. A coordinated workforce of suppliers can also be obtainable through the platform, together with dietitians, coaches and well being physicians.
The Illinois-based firm will use the funding to improve its expertise and increase its workforce.
“We’re thrilled to have the help of industry-leading capital companions as we execute on our imaginative and prescient at Vivante,” Invoice Snyder, Vivante Well being CEO, stated in an announcement. “One in 4 Individuals suffers from a digestive dysfunction or undiagnosed digestive signs that have an effect on their high quality of life in addition to their healthcare prices. We now have confirmed that our scalable expertise platform paired with our complete care workforce leads to higher well being, decrease prices and a a lot better expertise for the members we serve.”
MARKET SNAPSHOT
Vivante raised $16 million in Sequence A funding final yr, $5.8 million in Sequence A1 funding in 2020 and $6 million in 2018.
In 2022, Solera Well being, a digital platform that gives a market for advantages and power illness administration applications, introduced it was including Vivante and fellow digital gastrointestinal well being firm Oshi Well being to its market of advantages and power care administration instruments.
Different corporations within the digital gastrointestinal area embody Salvo Well being, which gives a digital clinic geared towards individuals with power intestine issues equivalent to irritable bowel syndrome, and Daring Well being, a London-based firm growing digital therapeutics for gastrointestinal situations.
[ad_2]
Source_link